Following off` virus reinfection in sheep, CD8 + T cells were recruited to the lesion site in the skin during the period of viral replication and appeared in increased numbers in afferent lymph draining the infection site. A proportion of the CD8 ÷ T cells were activated, particularly in the skin, as determined by their expression of the cytolytic cell-associated serine protease, BLTesterase. This was a useful marker for activated cytolytic cells as there was a good correlation between afferent lymph CD8 + T cell-mediated lysis of autologous off virus-infected skin cells and their expression of BLTesterase in vitro. The majority of the cells that expressed BLT-esterase in the skin and lymph were CD8 + T cells and cytolysis in vitro was predominately by the MHC class I antigen presentation pathway. The conclusion is that off`virus reinfection is characterized by limited viral replication and stimulation of an activated CTL response in the skin.
Introduction
Off is an acute debilitating skin condition of sheep and goats that also affects man (Robinson & Balassu, 1981) . The causative agent is off virus, a DNA parapoxvirus with a worldwide distribution. The virus enters its host via abrasions in the skin and replicates in regenerating epidermal cells (McKeever et al., 1988) . The orf lesion, which can be proliferative, progresses clinically from erythema to macule, pustule then scab. In primary infections of lambs this occurs within six weeks, whereas in subsequent reinfections the lesion size and time to resolution is reduced, indicating that a specific immune response is generated. The ability of the virus to repeatedly reinfect animals in spite of the host immune response is of immunological interest.
Histologically, the skin lesion is characterized by an early influx of neutrophils followed by ~6 receptor + T cells, CD4 + T cells, CD8 + T cells and B cells (Jenkinson et al., 1990 (Jenkinson et al., , 1992 . MHC class II + dendritic cells form a dense network of cells adjacent to and underlying the virus-infected epidermal cells (Jenkinson et al., 1991; Lear et al., 1996) . The dynamics of the immune response to orf virus infection in sheep has been studied in afferent and efferent lymph around the prefemoral or popliteal lymph nodes and showed an apparently normal CD4 + T * Author for correspondence. Fax +44 131 664 8001. e-mail Haigd@mri.sari.ac.uk cell and antibody response (Yirrell et al., 1989 as well as a pattern of lymph cell cytokine production typical of an antiviral immune response which included interferon-~ (IFN-cQ, IFN-y, interleukin-2 (IL-2), IL-lfl, IL-8, granulocyte/macrophage colony stimulating factor (GM-CSF) and tumour necrosis factor-0c (TNF-~) (Haig et al., 1992 (Haig et al., , 1996a ; N. Myatt, unpublished results). However, an interesting feature of both the skin and lymph response to viral reinfection is the numerical superiority of total and blast-transformed CD4 + T cells over CD8 + T cells (Lear, 1994; Haig et al., 1996a) . This, together with the fact that the virus is able to repeatedly reinfect sheep raises a question about the antiviral function of the CD8 + T cells in off`.
The purpose of this study was to determine whether CD8 + T cells in the skin and migrating in afferent lymph draining the affected skin site were activated and functionally antiviral as a consequence of in vivo reinfection with off` virus. Recent evidence suggests that cytotoxic T lymphocyte (CTL) production of perforin plus granzyme serine proteases is an important mechanism for killing virus-infected cells (Kagi et al., 1994; Lowin et at., 1994; Nakajima et al., 1995;  reviewed by Liu et al., 1995; Smyth & Trapani, 1995) . As a measure of CTL target cell killing we have employed an assay which measures release of target cell DNA and attempted to correlate this activity with secretion of the effector CTL serine protease BLT-esterase. In mouse and man, BLT-esterase has been identified as a tryptase involved in CTL activity and synonymous with granzyme-A and (Yirrell et al., 1991b) . This provides an opportunity to measure the local in vivo dynamics of CTL and their precursors (pCTL) generated during a live virus reinfection of its natural host and in its natural target organ -the skin.
Methods
Animals and virus infection. Female Finnish Landrace and Suffolk cross sheep between one and two years of age were used. Both breeds exhibit an indistinguishable clinical and skin histological response to orf virus infection. All animals were seropositive for orf virus, but the number of previous exposures was not known. In an attempt to standardize experience before reinfection, the sheep were infected with orfvirus between 8 and 10 weeks prior to experimental reinfection. The virus used was prepared from infected scab material kept as a stock at the Moredun Institute (McKeever et al., 1988) . For in vivo virus infection, skin in an area of the hind flank or inner thigh of the animals was scarified with a 16 gauge needle and ~ 106 orf virus particles were applied topically (Haig et al., 1996a) . Control animals received scarification and topical application of PBS only.
Skin lesion analysis, histology and histochemistry. Punch biopsies (6 mm) were taken at various time points prior to and following virus reinfection and immediately fixed in formalin/cacodylate/sucrose for 2-3 h at 4 °C as described previously (Jenkinson et al., 1990) . Following storage for up to 18 h in 0.4 M-sucrose at 4 °C, the specimens were then frozen in liquid nitrogen and stored at -70 °C. For quantification of lymphocyte subsets by immunohistology, four semi-serial 101am sections of each sample were cut at intervals of at least 50 gm prior to mounting on glass slides. For immunohistology, an avidin-biotin peroxidase technique was used (Vectastain Elite; Vector Laboratories). Primary antibodies were added to tissue sections overnight at 4 °C. Biotinylated horse IgG anti-mouse immunoglobulin was used as second stage reagent followed by horseradish peroxidase-labelled avidin-biotin complex. Primary antibodies used were the murine monoclonal antibodies (MAbs): SBU-T4 anti-ovine (ov) CD4 and SBU-T8 anti-ov CD8 (Maddox et al., 1985) ; 86-D anti-ov 73 T cell receptor (MacKay et al., 1988) ; 49.1 anti-ov MHC class II antigen (Puri et al., 1987) ; 73B anti-ov CD45 RA, B220 antigen which in sheep skin and afferent lymph is expressed on B cells and < 1% of T cells (MacKay et al., 1990) ; MAb 2E5 anti-off virus envelope protein (P. Nettleton & H. Reid, unpublished results); and polyclonal affinitypurified rabbit anti-ovine sheep mast cell protease (SMCP; Huntley et al., 1986) .
Lymphocyte BLT-esterase activity was detected in skin sections using the tryptase-specific substrate N-~-benzyloxy-carbonyl-L-lysine thiobenzyl ester (BLT; Sigma) as described previously (Kramer et al., 1989) . Sections were incubated with 10 _4 M-BLT, 5 mg/ml Fast Blue BB salt (Sigma), 0.2 M-Tris HC1 pH 8.1 for 30 min at room temperature and the reaction terminated by washing the slides in water. Ovine cutaneous mast cells also express the BLT-reactive enzyme SMCP (D. Haig, J. Huntley & A. Pemberton, unpublished results) . SMCP + mast cells in parallel thin (6 gin) skin sections were therefore identified and excluded from analysis. For combined histochemistry and immunohistology, sections were first stained for BLT-esterase and then with the antibodies to ov CD4, ov CD8, ov yfi T cells and CD45R (B220) B cells using the avidin biotin peroxidase method. To enhance detection of dual BLT-esterase and cell-surface alloantigen staining cells, vector red was used to reveal the immunohistological reaction to contrast with the yellow BLT-esterase reaction product.
Afferent lymph.
Techniques for the cannulation of lymph node ducts and lymph collection were as described (Haig et al., 1996 a) . Briefly, at least 14 weeks prior to cannulation, the prefemoral lymph node was removed and the various afferent lymphatics allowed to anastomose with a single efferent duct. The pseudo-afferent lymph obtained by cannulation of the extant efferent duct is referred to herein as afferent lymph. Lymph was collected in plastic bottles which were changed regularly and which contained heparin, penicillin and streptomycin. Lymph was processed at each collection to record total volume and differential cell counts. The phenotype of afferent lymph cells was analysed on cytocentrifuge preparations fixed with formalin/ cacodylate/sucrose and stained using the antibodies, avidin-biotin peroxidase and BLT-esterase detection methods described above. Mast cells or basophils were not detected in any of the lymph samples.
Skin cell cultures and CTL expansion. Skin biopsies were taken from each sheep ~ 6 weeks prior to reinfection, treated with 0.25 % w/v trypsin and cell lines prepared as described (Blacklaws et al., 1994) . Cells were cultured in Iscove's modification of Dulbecco's modified Eagle's medium containing penicillin, streptomycin and 10 % fetal calf serum (IMDM-FCS). Cultured skin cells were frozen in cryoprotectant after three passages. The heterologous skin cell line was obtained from a Dorset lamb. For the in vitro development of lymph CTL from precursor cells (pCTL), two rounds of in vitro stimulation of lymph cells using orf virus-infected autologous skin cells and IL-2 were performed based on previously described techniques (Blacklaws et al., 1994) . Briefly, lymph cells were cultured in 24-well plates (Costar) at 2 x l0 s cells/ml in IMDM-FCS with 105 autologous skin cells that had been infected 2 h previously with 0.5 TCIDs0/cell of a tissue cultureadapted strain of orf virus (Scabbyvax; CSL, Melbourne, Australia). After 3~4 days, 20 U/ml of recombinant human IL-2 (Glaxo/Biogen, Switzerland) was added to the cultures. After a further 34 days the cells were harvested, resuspended to 106 viable cells/ml and the culture procedure repeated for a further 7 days using fresh autologous orf virus-infected cells plus IL-2. The cells were phenotyped by FACScan analysis and were > 86 % CD8 + T cells and < 7 % CD4 ÷ T cells and B cells.
Fractionation of lymph CD8 + T cells. The MACS magnetic particle separation system was used according to the manufacturer's instructions (Miltenyi Biotec, Germany). Aliquots of 107 lymph cells in PBS/1% FCS/5 mM-EDTA were incubated with MAb SBU-T8 for 40 min at 4 °C. The washed cells were then incubated with goat antimurine IgG-coated magnetic microbeads in 100 lal aliquots for 20 min at 4 °C. The labelled cells were passed through MACS separation columns attached to a MACS permanent magnet and CD8 cellenriched fractions collected in the fall through. After several washes, the column was removed from the magnetic field and CD8 + T cellenriched fractions collected. The purity of the collected fractions was checked after overnight culture of cell aliquots at 37 °C, followed by staining cytocentrifuge preparations with SBU-T8, SBU-T4, CC15 (anti-bovine/ovine T-19 antigen ofy6 T cells; Morrison & Davis, 1991) and 73B MAbs using the avidin-biotin peroxidase method as described above.
CTL assay. The ability of lymph cells to kill orf virus-infected, Semliki Forest virus (SFV)-infected, uninfected autologous and orf virus-infected heterologous skin cells was measured in a 12 h CTL assay using target cell (T) DNA release (Cellular DNA fragmentation ELISA; Boehringer Mannheim) as a measure of cytolysis. DNA release from target cells will be referred to as nucleolysis and the assay will be referred to as the nucleolysis assay. Effector lymph cell (E) BLTesterase secretion was also measured. Skin cells were plated at 10*/well in flat-bottomed 96-well plates in DMEM lacking phenol red (Gibco-BRL) but containing 100 gg/ml gentamicin, 5 x 10 -5 M-2-mercaptoethanol and 10 % FCS. BrdU (10 ~tg/ml final concentration) was added for 6 h. The cells were washed and infected where appropriate with 0.5 TCIDs0/cell of orf virus or 0-5 TCIDs0/cell of control SFV for 1 h at 37 °C. The dose of each virus was selected to allow at least 18 h of infection in the absence of a visible cytopathic effect. After a further wash, effector cells at various effector:target cell ratios were added with and without blocking antibodies and cultures incubated for 12 h at 37 °C in a humid atmosphere of 5 % CO 2 in air. Although nucleolytic activity could be detected after 8 h in most cases, a 12 h assay was optimum for both direct and pCTL assays as determined by preliminary experiments. Following culture, cell-free supernatants and cell lysates (in distilled/deionized water) were collected and analysed for nucleolysis (BrdU-labelled DNA release) by ELISA (Boehringer Mannheim). Specific nucleolysis (%) was calculated from: (mean A4~ 0 experimental nucleolysis-mean A4~ 0 control nucleolysis)/(mean A4~ 0 total target cell lysate nucleolysis-mean A450 control nucleolysis). Samples were assayed in quadruplicate. Control background target cell nucleolysis was < 15% of the total obtained from the cell lysates.
BLT-esterase was measured as described previously (Trapani et al., 1994) with minor modification. Briefly, supernatant or lysate samples (50 gl) were added to 96-well fiat-bottomed plates and 200 gl of a mixture of 0.3 mM-BLT and 0.33 mM-dithio-bis-(2-nitrobenzoic acid) in PBS pH 7.2 was added (both reagents from Sigma). Incubation was for 1 h at 37 °C. The reaction was terminated by placing the plates on ice and adding 5 ~tl of 5 mM-Pefabloc (Boehringer Mannheim) protease inhibitor/well. Plates were read on an ELISA plate reader and enzyme activity expressed as A4a ~ units/h at 37 °C/ml sample (absU/h/ml).
The antibodies used for blocking studies were: SBU-MHC-I plus VPM 19, anti-ovine MHC class I (Puri et al., 1987) ; and 49.1 anti-ovine MHC class II antigen. Antibodies were used at a total immunoglobulin concentration of ~ 5 gg/ml based on preliminary dose-response experiments. The 49.1 MAb had been previously used at this concentration to block antigen presentation to CD4 + T cells (Haig et al., 1989) . Control MAbs were isotype matched and specific for Border Disease virus epitopes (G. Entrican, Moredun Research Institute).
Statistics. The paired Student's t-test was applied to log-transformed data where appropriate. Regression analysis (95 % confidence limit) was performed to determine the correlation between effector cell BLTesterase release and target cell DNA release in the CTL assays.
Results

Clinical observations
Off lesions in all animals following virus reinfection proceeded through the clinical stages of erythematous macule, papule, pustule and scab formation with macroscopic resolution by day 12. Lesion size was similar in all sheep and was at a maximum between days 5 and 7. Control scarified animals showed a transient erythema and scab formation which in all cases had resolved within five days. 
BLT-esterase in afferent lymph cells
Daily samples of afferent lymph cells draining control scarified or virus-reinfected skin sites were analysed for BLT-esterase expression by histochemistry. The frequency of BLT-esterase + cells in the lymph cytocentrifuge samples from the control scarified group (n --3) was < 1% of total cells at all time points (Fig. 1) . CD8 + T cells did not fluctuate significantly. In contrast, the frequency of BLT-esterase + and CD8 + cells increased significantly between 6 and 10 days following virus reinfection (n = 5; P < 0"005 for day 10 compared to control group or preinfection values, Fig, 1 ). At all time points > 80 % of the BLT-esterase + cells were CD8 + and less than 10 % were CD4 + or T19 ÷. BLT-esterase was not observed in CD45R + B cells or afferent lymph dendritic cells. Between days 8 and 12 following reinfection, 10-13 % of the total CD8 ÷ T cells expressed BLT-esterase. The differential afferent lymph cell analysis for these animals has been described elsewhere (Haig et al., 1996a) . Following reinfection, maximum lymph cell output was recorded between days 6 and 10; two lymphoblast peaks were recorded between 4 and 7 days and then again between 8 and ! l days; and CD4 + T cell output exceeded that of either CD8 + T cells, B cells or T19 + T cells at all time points. 
Direct cytolytic activity of afferent lymph cells in vitro
To determine whether afferent lymph cells were capable of direct (without preculture) cytolytic activity against orf virus-infected target skin cells in culture and whether this activity was associated with BLT-esterase release from the effector cells, target cell nucleolysis and BLTesterase was measured in lymph effector cell lysates and in culture supernatants. A time course study was performed using lymph cells from frozen stock. In this way the relative nucleolytic activities of the different samples from each of the individual sheep were compared in a single test. Frozen cells retained 50-75% of the (10) 72-0_+8.1 11.5_+0.8 Total (2) 36.4 + 5.0 5.7 + 0.5 Total (10) anti-MHC I 10.7+4.4 5.3+0.5 Total (10) anti-MHC II 68.9_+8.1 9.6_+ 1.0 nucleolytic activity of fresh cells (n = 5, unpublished results; see below). In the control scarified group (n = 2), a maximum of 14 % specific nucleolysis from orf virusinfected skin cells was recorded on day 0 at an E: T ratio of 40: 1. At subsequent time points (day 5, day 10) less than 12% specific nucleolysis was recorded. BLTesterase did not exceed 3 absU/ml/h in any sample in this group. In the reinfection group (n = 4), the afferent lymph cell nucleolytic activity was targeted preferentially to orf virus-infected autologous skin cells in a effector cell dose-dependent manner. Fig. 2 (a) shows the time course of the nucleolytic response at an E:T ratio of 40: 1. The response was significant (P = 0.008) at this E:T ratio on day 15 compared to day 0. Some nonspecific nucleolytic activity against SFV-infected (but not uninfected) autologous skin cells was also observed (Fig.  2a) .
There was an effector cell dose-dependent increase in lymph cell BLT-esterase activity in cell-free supernatants (CFS) from cultures containing orf virus-infected autologous skin cells. Fig. 2 (b) shows the response at an E:T ratio of 40:1. BLT-esterase activity in all lymph cell lysates prior to assay was within the range 0.5-1.5 absU/ml/h and in cell lysates from non-virus containing control wells at the end of the 12 h assay was < 0.5 absU/ml/h. This indicated that a degree of non- specific release had occurred in the control cultures, which was confirmed by the dose-dependent increase in BLT-esterase levels recorded in the CFS of these cultures ( Fig. 2b for an E:T ratio of 40:1). In the cultures containing orf virus-infected autologous target cells, lymph cell BLT-esterase had apparently been induced as the amount of enzyme detected after 12 h of culture (range: 2"54.5 absU/h/ml) exceeded the amount obtained from cell lysates prior to culture (range 0.5-1'5 absU/h/ml)(P < 0.01). The target cells were not a source of BLT-esterase. There was a good correlation (r2> 0-89, P < 0.03 for all time points) when specific target cell nucleolysis at various E:T ratios at each time point was compared to effector cell BLT-esterase activity in the culture supernatants. In order to determine the phenotype and MHC restriction of the effector lymph cells, CD8 + T cells and CD8-cells in day 12 post-reinfection lymph samples were fractionated by MACS and cultured in the CTL assay in the presence and absence of anti-MHC class I and anti-MHC class II neutralizing antibodies. Table 1 shows that the direct nucleolytic activity and BLT-esterase expression mapped predominantly to CD8 + T cells and the MHC class I restriction pathway. The cells used in this analysis were taken from overnight lymph collections (fresh, Table 1 ) and showed increased nucleolytic activity compared to the same batch of cells taken from frozen stock.
Afferent lymph CTL precursors
To explore the relationship between CD8 + T cell BLTesterase expression and nucleolysis further, afferent lymph CTL precursors were expanded in cultures of orf virus-infected autologous skin cells and used as effector cells in the CTL assay. Successful expansion of CD8 + T cells (> 86 % purity) was achieved for 3 of 4 animals in the reinfection group, from samples taken on days 0, 2 and 12 with respect to reinfection. Fig. 3 (a, b) shows that the cultured cells exhibited a dose-dependent nucleolysis of orf virus-infected autologous skin cells with an associated effector cell release of BLT-esterase. There was good correlation (r2> 0-90, P < 0.01 for all time points) between dose-dependent CD8 + T cell-induced target cell nucleolysis and BLT-esterase activity. There was marked dose-dependent effector lymph cell BLTesterase secretion in the control cultures (Fig. 3 b) . This non-specific release of BLT-esterase or granzymes has been described previously in cultured cells (Griffiths & Mueller, 1991) and is thought to be due to the induction of enzyme expression and secretion by cytokines including IL-2 (Liu et al., 1989) . Table 1 shows that both CD8 + T cell-mediated specific nucleolysis and BLTesterase release in the cultures of off virus-infected skin cells were inhibited by 84 % and 48 %, respectively in cultures containing antibody to MHC class I compared to those containing antibody to MHC class II.
CD8 + and BLT-esterase + lymphocytes in the skin
The above experiments demonstrated that lymph cells expressing BLT-esterase increased following orf virus reinfection and that enzyme release was associated with nucleolysis of orf virus-infected autotogous skin cells in vitro. We wished to determine whether CD8 + T cells localized in orf-affected skin were activated as measured by BLT-esterase expression and at what time in relation to reinfection any activated cells appeared.
Orf virus antigen was detected in vacuolated cells above regenerating epidermal cells between days 3 and 12 after reinfection, with maximum staining intensity on day 6 in all cases. The staining intensity of off virus antigen coincided with the magnitude of the skin lesions as has been described previously where both the presence of virus antigen and lesion development were the consequence of viral replication (McKeever et al., 1988;  Jenkinson et al., 1990 Jenkinson et al., , 1991 Lear et al., 1996) . Orf virus antigen was not detected in skin sections from scarification-only control animals. Fig. 4 shows that CD8 + T cells increased in number in the dermis between 2 and 6 days following reinfection, after which they declined. The cells were located adjacent to and underlying orf virus-infected epidermal cells. BLTesterase + cells, > 80 % of which were CD8 + T cells, increased and declined in number along with the total CD8 + T cells. At the peak of virus antigen expression in epidermal cells (and maximum lesion size) on day 6, BLT-esterase +, CD8 + T cells constituted 32 % ± 6 SEM of the total CD8 + T cells in the dermis. In control skin sections (n = 4), a small and transient increase in CD8 + T cells (< 15 total CD8 + and < 2 BLT-esterase + per mm ~ dermis) was recorded on days 2 and 3 after scarification.
Discussion
The dynamics of total and activated CD8 ÷ T cells responding to off virus reinfection has been studied in the skin lesion and in afferent lymph draining from the lesion in sheep. CD8 ÷ T cells were recruited to the skin site of reinfection during the period of viral replication. A subpopulation of these was assumed to be activated as measured by cytoplasmic expression of the serine protease BLT-esterase. These cells were located adjacent to and underneath the off virus-infected epidermal cells and not in blood vessels which would indicate that they had been activated in the skin and had not arrived from the blood as BLT-esterase ÷ cells. During the period when viral antigen was most abundant and CD8 ÷, BLTesterase ÷ T cells were at their most numerous in the skin, there was no increase in the number of these cells migrating from the lesion in the afferent lymph. This is consistent with trapping of CD8 ÷ T cells at this time in the lesion and activation with subsequent degranulation/ secretion of enzyme on encountering off virus-infected cells. As the numbers of CD8 ÷, BLT-esterase ÷ T cells declined in the skin from day 6 after reinfection their numbers increased transiently in the afferent lymph, albeit at very low frequency. This possibly reflects the migration of cells that had been activated to express but not secrete BLT-esterase in the skin during the later period of reinfection when off virus was located principally in the scab.
BLT-esterase activity in mouse and man is associated with granzyme-A, a serine protease with tryptase activity (Kramer et al., 1989) . Granzyme-A is the only tryptase out of a series of granzyme proteases that are expressed along with perforin as part of the calcium-dependent granule exocytosis lytic pathway used by CTL and NK cells (Gershenfeld et al., 1988) . Granzymes A and B are the predominant secreted/exocytosed granzymes and have been shown to fragment DNA in target cells perforated by perforin as part of the sequence of events leading to cell lysis (Shiver et al., 1992; Shi et al., 1992) .
BLT-esterase or granzyme-A expression has been used as a diagnostic marker for the activity of cytolytic cells in vivo (Griffiths & Mueller, 1991) . In this study the usefulness of BLT-esterase expression as an indicator of cytolytic activity was extended to sheep infected with off virus. BLT-esterase expression and secretion from effectot lymph cells correlated in a dose-dependent way with the ability of cells to induce nucleolysis in orf virusinfected autologous skin cells in vitro and could therefore be used as a marker of specific cytolytic activity in vivo. BLT-esterase was expressed predominantly in CD8 ÷ T cells, and the bulk of the in vitro nucleolytic activity was mediated by these cells using the MHC class I pathway. However BLT-esterase was also observed in CD4 ÷ and ~6 ÷ T cells, cell types which have been demonstrated to express BLT-esterase/granzyme-A in other species (Garcia-Sanz et al., 1987; Koizumi et al., 1991) . Whether the ovine lymphocyte BLT-esterase is the ovine equivalent of granzyme-A is not known. Antibodies to human and murine granzyme-A (courtesy of Gillian Griffiths, Basel Institute for Immunology) do not react with ovine cells and the ovine enzyme has not been isolated.
An apparent direct afferent lymph cell-induced nucleolysis of off virus-infected cells in vitro without previous expansion of pCTLs in culture was recorded.
There are only a few reports of direct CTL-mediated lysis of target cells [efferent lymph CTL in vaccinia-infected sheep (Issekutz, 1985) ; HIV-infected patients (Nixon, 1992) ; Maedi-visna virus-infected sheep (Blacklaws et aI., 1994) ]. The use of the ELISA to detect specific target cell DNA may have helped to reveal this phenomenon as background release values for control skin cell cultures were low (which also showed that there was no significant contribution of an off virus or SFV-induced cytopathic effect to nucleolysis over the 12 h of the assay). However, ovine afferent lymph (D. Yirrell, unpublished results), efferent lymph (Issekutz, 1985) and peripheral blood CTL (Blacklaws et al., 1994 ) also exhibited direct lysis of skin cells labelled with 51chromium or lnindium. A more interesting possibility is that afferent lymph draining the infection site was enriched in antigen-specific pCTL or activated CTL such that direct lysis of virus-infected autologous target cells in culture was detectable. Although not great compared to assays using in vitro expanded pCTL, significantly increased direct nucleolysis compared to day 0 was recorded on day 15 following reinfection, at which time the lesion had resolved. A possible explanation is that during the period of maximum off virus replication (i.e. maximum lesion size and virus antigen staining intensity in skin sections, 3-8 days post-reinfection), antigen-specific pCTLs and directly lytic CD8 ÷ T cells were recruited as part of a general lymphocyte recruitment and subsequently became trapped in the lesion where they expressed their lytic mediators. They would therefore not be detected in increased numbers in the afferent lymph during this time. As only a proportion of the total CD8 ÷ T cells expressed BLT-esterase in the skin or afferent lymph, an antigenspecific response is implicated if not proven.
An increase in BLT-esterase in the cultures containing orf virus-infected autologous skin cells at the end of the 12 h direct or 14 day cultured CTL assays compared to levels at the start of the assays showed that afferent lymph cell expression of BLT-esterase had been induced. In the case of the direct assays, it may therefore be inappropriate to call them direct. The contribution to the observed nucleolysis of the few cells expressing BLTesterase at the start of the culture versus those induced to express the enzyme during culture is not known. A 12 hour time period for the nucleolysis assay was the optimum for the detection of nucleolytic responses. An extended assay period 06-18 h) was also necessary for some CTL assays using blood and lymph effector cells in sheep infected with Maedi-visna virus (Blacklaws et al., 1994) .
The results of this study show that off virus reinfection stimulated a measurable skin and afferent lymph activated CD8 ÷ T cell response. In spite of the presence in the skin of CD8 ÷, BLT-esterase ÷ cells, the virus was able to replicate for several days. These cells are therefore not fully protective. Cytolytic cells would be most effective when acting early on in reinfection, prior to virion production. Orf virus, like all poxviruses, replicates intracytoplasmically and is released from burst cells. The effect of cytolysis after 3 days post-reinfection would probably be only partially effective. In this respect it is interesting that there is no evidence of off virus antigen for 2 days following reinfection (Jenkinson et al., 1990) and there was no appreciable recruitment of CD8 + T cells during this time (Fig. 4) . However, BLT-esterase +, CD8 ÷ T cells were present in the lesion on day 3 and for the duration of the period when clinical lesions were present and viral antigen was detected in the skin sections. Previous studies have shown that reinfection orf lesions were smaller, involved less viral replication and resolved quicker than primary lesions (McKeever et al., 1988; Jenkinson et al., 1990 Jenkinson et al., , 1991 Lear et al., 1996) . This suggests that a specific anamnestic immune response is important in controlling the infection if not preventing it. The CD8 +, BLT-esterase + T cells may be involved in this. Whether the CD4 + T cells which predominate in the lesion and lymph have any antiviral function is not known. Protection against vaccinia virus in mice is thought not to be dependent on CD8 + T cells (Spriggs et al., 1992) and CD4 + T cell involvement is implied. Orf virus-specific antibodies are detected in afferent and efferent lymph following orf virus reinfection (Yirrell et al., 1989 and it is possible that these also help to contain the virus in the degenerated epidermis and the scab.
A reason for the ineffectiveness (at least transiently) of an active immune response against orf virus may be that the virus has acquired or evolved the genetic capability to evade host immune and inflammatory responses. This has been demonstrated for other poxviruses (Pickup, 1994; Alcami & Smith, 1995) . For example vaccinia virus encodes genes for proteins that block and inactivate the cytokines IFN-~, IFN-7, IL-lfl and TNF-~ as well as those that interfere with IL-lfl production or interferoninduced intracellular kinase activation (Alcami & Smith, 1995) . This demonstrates the importance of these cytokines to the host protective immune response. Vaccinia virus can also interfere with MHC class Irestricted CTL generation, although the mechanism is not known (Townsend et al., 1988) . Less is known about orf virus in this respect although virulence factors are being discovered (Lyttle et al., 1994; Haig et al., 1996b) . It will be of interest to determine whether orf virusinfected cells produce factors capable of blocking the cytolytic enzymes of CTL.
